Medtronic plc — Form 10-Q
Filed September 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Geoffrey S. Martha (CEO) and Thierry Piéton (CFO) certify per Sarbanes-Oxley §302 and §906 that the Form 10-Q for quarter ended July 31, 2026 fairly presents financial condition and results of operations, disclosure controls are effective, and no material weaknesses or fraud involving management in internal controls were identified. This is boilerplate executive certification required for all public company quarterly filings.
Why this rating
Routine Sarbanes-Oxley certifications; no operational, financial, or control changes disclosed. Standard periodic filing requirement.
See more from September 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.